AJP - Heart pressure measurements
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 286: H1236-H1241, 2004. First published December 4, 2003; doi:10.1152/ajpheart.00950.2003
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/4/H1236    most recent
00950.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, T.-S.
Right arrow Articles by Hamano, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, T.-S.
Right arrow Articles by Hamano, K.

Low angiogenic potency induced by the implantation of ex vivo expanded CD117+ stem cells

Tao-Sheng Li, Masanori Hayashi, Ze-Lin Liu, Hiroshi Ito, Akihito Mikamo, Akira Furutani, Masunori Matsuzaki, and Kimikazu Hamano

Department of Medical Bioregulation, Division of Cardiovascular Surgery and Medicine, Yamaguchi University School of Medicine, Yamaguchi 755-8505, Japan

Submitted 9 October 2003 ; accepted in final form 24 November 2003

Ex vivo expansion of stem cells might be a feasible method of resolving the problem of limited cell supply in cell-based therapy. The implantation of expanded CD34+ endothelial progenitor cells has the capacity to induce angiogenesis. In this study, we tried to induce angiogenesis by implanting expanded CD117+ stem cells derived from mouse bone marrow. After 2 wk of culture with the addition of several growth factors, the CD117+ stem cells expanded ~20-fold and had an endothelial phenotype with high expression of CD34 and vascular endothelial-cadherin. However, >70% of these ex vivo expanded cells had a senescent phenotype by {beta}-galactosidase staining, and their survival and incorporation were poor after implantation into the ischemic limbs of mice. Compared with the PBS injection only, the microvessel density and the percentage of limb blood flow were significantly higher after the implantation of 2 x 105 freshly collected CD117+ cells (P < 0.01) but not after the implantation of 2 x 105 expanded CD117+ cells (P > 0.05). These data indicate that ex vivo expansion of CD117+ stem cells has low potency for inducing therapeutic angiogenesis, which might be related to the cellular senescence during ex vivo expansion.

ischemic; blood flow; senescence; differentiation



Address for reprint requests and other correspondence: K. Hamano, Div. of Cardiovascular Surgery, Dept. of Medical Bioregulation, Yamaguchi Univ. School of Medicine, Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan (E-mail: kimikazu{at}yamaguchi-u.ac.jp).




This article has been cited by other articles:


Home page
CirculationHome page
T.-S. Li, M. Kubo, K. Ueda, M. Murakami, M. Ohshima, T. Kobayashi, T. Tanaka, B. Shirasawa, A. Mikamo, and K. Hamano
Identification of Risk Factors Related to Poor Angiogenic Potency of Bone Marrow Cells From Different Patients
Circulation, September 15, 2009; 120(11_suppl_1): S255 - S261.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Di Stefano, C. Cencioni, G. Zaccagnini, A. Magenta, M. C. Capogrossi, and F. Martelli
p66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose
Cardiovasc Res, June 1, 2009; 82(3): 421 - 429.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Kubo, T.-S. Li, R. Suzuki, M. Ohshima, S.-L. Qin, and K. Hamano
Short-term pretreatment with low-dose hydrogen peroxide enhances the efficacy of bone marrow cells for therapeutic angiogenesis
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2582 - H2588.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. K. Haider and M. Ashraf
Bone marrow stem cell transplantation for cardiac repair
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2557 - H2567.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T.-S. Li, H. Ito, M. Hayashi, A. Furutani, M. Matsuzaki, and K. Hamano
Cellular expression of integrin-{beta}1 is of critical importance for inducing therapeutic angiogenesis by cell implantation
Cardiovasc Res, January 1, 2005; 65(1): 64 - 72.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Massa, V. Rosti, M. Ferrario, R. Campanelli, I. Ramajoli, R. Rosso, G. M. De Ferrari, M. Ferlini, L. Goffredo, A. Bertoletti, et al.
Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction
Blood, January 1, 2005; 105(1): 199 - 206.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.